PDI Rx Licensing Strategy Puts CSO In Competition With Small Manufacturers
Executive Summary
PDI's breach of contract settlement with Auxilium is a result of the contract sales organization's new strategy of competing with small pharmaceutical manufacturers
You may also be interested in...
PDI Combing Urology, Neurology Markets For Licensing/Acquisition Deals
PDI is aiming to build a "long-term portfolio" of specialty products through licensing deals, beginning in the urology and neurology markets
PDI Combing Urology, Neurology Markets For Licensing/Acquisition Deals
PDI is aiming to build a "long-term portfolio" of specialty products through licensing deals, beginning in the urology and neurology markets
PDI Evista Lessons Learned: Firm Focuses On Smaller Contracts, No Baselines
PDI will focus on smaller contract sales opportunities in the 50-representative range following termination of the Evista promotion deal with Lilly, CEO Charles Saldarini said on a conference call Nov. 12